Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Shugo Kowata"'
Autor:
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Takafumi Nakao, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Satoshi Iyama, Junki Inamura, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Shinya Kimura
Publikováno v:
HemaSphere, Vol 7, p e9072115 (2023)
Externí odkaz:
https://doaj.org/article/5d46986c1a534c98a9f192f73aea65a5
Autor:
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Takafumi Nakao, Takero Shindo, Satoshi Iyama, Junki Inamura, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Atsushi Kawaguchi, Shinya Kimura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::764c8ea9ebed868c1b626453b00f7124
https://doi.org/10.2139/ssrn.4402720
https://doi.org/10.2139/ssrn.4402720
Autor:
Masataka, Kuwana, Tomoki, Ito, Shugo, Kowata, Yoshihiro, Hatta, Katsumichi, Fujimaki, Kensuke, Naito, Shingo, Kurahashi, Toshiya, Kagoo, Kazuki, Tanimoto, So, Saotome, Yoshiaki, Tomiyama, Tomofumi, Yano
Publikováno v:
British journal of haematologyREFERENCES.
Fostamatinib, a spleen tyrosine kinase inhibitor, has been approved for the treatment of chronic primary immune thrombocytopenia (ITP) in the United States, Canada and some European countries. We conducted a phase 3, placebo-controlled, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b830746b2212704fafc51fb011ecab
https://pubmed.ncbi.nlm.nih.gov/36470677
https://pubmed.ncbi.nlm.nih.gov/36470677
Publikováno v:
Internal Medicine
Acute liver injury (ALI) has been rarely reported as a clinical finding of adult T-cell leukemia/lymphoma (ATLL). A 74-year-old Japanese female patient who was histologically diagnosed as having autoimmune hepatitis (AIH) one year earlier, showed ele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25871ec12d07c41f5d1ef46bffbb0fea
https://doi.org/10.2169/internalmedicine.6793-20
https://doi.org/10.2169/internalmedicine.6793-20
Autor:
Kazuki, Kiyohara, Norifumi, Sugawara, Takahiro, Maeta, Shinri, Miyajima, Motoki, Takano, Masao, Nishiya, Maki, Nishiya, Ryousei, Sasaki, Yoshiaki, Okano, Satsuki, Kamihara, Shugo, Kowata, Tatsuo, Oyake, Shigeki, Ito
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(10)
A 67-year-old woman diagnosed with adult T-cell leukemia/lymphoma received an induction chemotherapy and showed a partial response. She then underwent allogeneic peripheral blood stem cell transplantation from an HLA-identical sibling donor. Although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d84e24b6b2d40e9081a3bc1115336d74
https://pubmed.ncbi.nlm.nih.gov/34732623
https://pubmed.ncbi.nlm.nih.gov/34732623
Autor:
Takaaki Chou, Nozomu Fujimoto, Kohmei Kubo, Kazunori Murai, Shugo Kowata, Souichi Saito, Kohei Yamaguchi, Takahiro Mine, Takahiro Nagashima, Kazuhiko Ikeda, Yoji Ishida, Takuto Miyagishima, Koji Oba, Reiko Watanabe, Motohiro Shindo, Masakatsu Yonezumi, Yasuhiko Tsukushi, Shinji Sato, Satoshi Yamamoto, Takeshi Kondo, Kentaro Wakasa, Mitsue Inomata, Kuniaki Meguro, Katsushi Tajima, Shigeki Ito, Tatsuo Oyake, Junichi Sakamoto
Publikováno v:
European Journal of Haematology. 100:27-35
Objectives We conducted a phase-II study to evaluate the efficacy and safety of dasatinib in patients newly diagnosed with chronic-phase chronic myeloid leukaemia (CML-CP) in Japan (IMIDAS PART 2 study). Methods Seventy-nine patients were administere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f836d92c589ed4f37b2597a82c87b4c
https://doi.org/10.1111/ejh.12969
https://doi.org/10.1111/ejh.12969
Autor:
Yasutaka Kakinoki, Junichi Sakamoto, Reiko Watanabe, Tetsuo Nishimoto, Masayuki Hino, Kazuhiko Ikeda, Tsutomu Sato, Yoji Ishida, Takaaki Hosoki, Tsutomu Kobayashi, Shugo Kowata, Motohiro Shindo, Shinya Kimura, Nobuhiko Uoshima, Toshio Kitawaki, Hiroshi Ureshino, Akifumi Takaori-Kondo, Hideo Tanaka, Masaya Okada, Naoki Takezako, Hirohisa Nakamae, Jun Imagawa, Hirohiko Shibayama, Atsushi Kawaguchi, Kazunori Murai, Takayuki Ikezoe, Masaya Hayakawa, Takashi Kumagai
Publikováno v:
The Lancet. Haematology. 7(3)
Summary Background A previous dasatinib discontinuation (DADI) trial showed that 31 (49%) of 63 patients with chronic-phase chronic myeloid leukaemia who were treated with second-line or subsequent dasatinib could discontinue the drug safely. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e464da453c792f6533b067b4d61903b3
https://pubmed.ncbi.nlm.nih.gov/31978329
https://pubmed.ncbi.nlm.nih.gov/31978329
Autor:
Yukiteru Fujishima, Norifumi Sugawara, Shigeki Ito, Tatsuo Oyake, Yuka Takemasa-Fujisawa, Yoji Ishida, Yasuhiko Tsukushi, Ichiro Hanamura, Takahiro Mine, Shugo Kowata, Yusei Aoki
Publikováno v:
Annals of hematology. 98(5)
Febrile neutropenia is often observed in patients with hematologic malignancies, especially in those with acute leukemia. Meropenem has potent and broad antibacterial activity against gram-positive and gram-negative bacteria, and is recommended as fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de68ccf1b315208ecd9c8f1aa7a56fb0
https://pubmed.ncbi.nlm.nih.gov/30824955
https://pubmed.ncbi.nlm.nih.gov/30824955
Autor:
Shugo Kowata, Yoji Ishida
Publikováno v:
Autoimmune Thrombocytopenia ISBN: 9789811041419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa2fe41a88a1fc0f93e66f5ecacfad9c
https://doi.org/10.1007/978-981-10-4142-6_15
https://doi.org/10.1007/978-981-10-4142-6_15
Autor:
Shugo Kowata, Yoji Ishida
Publikováno v:
Autoimmune Thrombocytopenia ISBN: 9789811041419
Platelets are formed from the cytoplasm of megakaryocytes (MKs) that reside in the bone marrow (BM). MKs arise from hematopoietic stem cells in the osteoblastic niche in BM. The primary regulator of megakaryopoiesis is thrombopoietin. It is generally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05711ec584859ebbbe0f772da060dddc
https://doi.org/10.1007/978-981-10-4142-6_2
https://doi.org/10.1007/978-981-10-4142-6_2